← Back to all trials
Completed
NCT05631782
Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients
Conditions: Chronic Renal Failure, Hemodialysis
Sex: All
Ages: 52 Years – 65 Years
Phase: EARLY_PHASE1
Enrollment: 160
Sponsor: The First People's Hospital of Zunyi
Location: China
Summary
To explore the clinical effect of Shenkang Decoction in chronic renal failure (CRF) patients with hemodialysis (HD).
Eligibility Criteria
Inclusion Criteria:The diagnosis of western medicine meets the diagnostic criteria of chronic kidney failure in Internal Medicinethe diagnosis of TCM meets the diagnostic criteria of the disease in the Guiding Principles for Clinical Research of New Chinese Medicine.The patient is over 18 years old,can think independently and have civil conduct,strictly follow the doctor's advice,maintain stable condition and regular HD treatment.Exclusion Criteria:Patients with HD time of no more than three months, severe uncontrolled infection, other malignant diseases, heart, liver, brain, and digestive system dysfunction, mental diseases such as dementia or depression;contraindications to HD or contraindications to the study (Shock or systolic blood pressure below 80mm/Hg, severe bleeding or a tendency to bleed, serious infection such as sepsis, or a blood-borne infection, advanced tumor, extremely debilitating or not cooperating with doctor)drug allergy, chronic use of glucocorticoids, and immunosuppressants.women during pregnancy or lactation.
Source: ClinicalTrials.gov (NCT05631782). StuddyBuddy aggregates publicly available trial information.